Quantcast Cold Antibodies - Immunohematology and Blood Banking II

Share on Google+Share on FacebookShare on LinkedInShare on TwitterShare on DiggShare on Stumble Upon
Custom Search
 
  
 
(2)  Variation in the strength of the antigen. Some antigens that do not show
dosage in terms of zygosity may vary in strength on cells from different individuals. The
antigens most notable for this are P1, Sda, Lea, Leb, and I. Sometimes diminished
antigenic strength can be related to disease, or to the length of time that the cell
suspension has been stored.
1-38. COLD ANTIBODIES
a. Background. These antibodies react best at room temperature (RT) and
below, while reactions after 37C incubation and with AGT are negative or weakly
positive. Some cold agglutinating antibodies, notably anti-I, anti-lH, and anti-H, bind
complement following the antigen-antibody interaction at low temperatures; subsequent
37C incubation may cause the antibody to elute from the cell, but the attached
complement remains, and produces a positive reaction when antiglobulin serum is
added. An antibody displaying these characteristics in the screening test or in
crossmatches should be tested at 18C and/or 4C with specially selected cells, such as
cord cells.
b. Cold Autoabsorption to Remove Cold-Reactive Autoantibody.
(1)  When a strong, cold, autoantibody is present, meaningful
antibody-screening and compatibility studies cannot be done until the autoantibody is
removed. This can be done with the patient's untreated or enzyme-treated cells.
Enzyme pretreatment results in faster antibody removal, and is more effective with very
high-titered autoantibodies. Untreated autoabsorption is usually satisfactory for
removing low-level activity.
(2)  Some alloantibody may also be removed by the Matuhasi-Ogata
phenomenon, or by transfused cells in the circulation. In recently transfused patients,
when autoabsorption might result in removing alloantibody activity, the
antibody-screening test and compatibility tests should be done at 37C, using serum
from a blood sample clotted at 37C and kept at that temperature until the serum is
removed. This permits detection of antibodies active at 37C, and by AGT, but not
cold-reactive alloantibodies.
(a) STEP 1. Obtain a blood specimen from the patient. At the bedside
draw two specimens of blood, one in a tube immediately placed in ice, the other in a
tube containing anticoagulant and incubate it at once at 37C. To do this, bring a
heated block, water bath, or vacuum jug of 37C water to the patient's bedside. The
tube may also be transported in an inside pocket.
(b) STEP 2. Allow the first (iced) specimen to clot in the refrigerator.
Separate the serum by centrifuging in ice-filled cups or a refrigerated centrifuge.
Immediately remove the serum from the clot.
MD0846
1-52



Medical News
Synthetic pot sends hundreds to ERs in past month
(HealthDay)—In the past month, more than 300 people in Alabama...
medicalxpress.com
India's bidi workers suffer for 1,000-a-day habit
Zainab Begum Alvi and her band of young helpers hunch...
medicalxpress.com
Slippery Slope: Diet Drugs No Help for Heart
(MedPage Today) -- In another edition of the Slippery Slope...
medpagetoday.com
Slippery Slope: $$ in, Diet Drugs Out, How Five Drugs Came to Market
(MedPage Today) -- Makers of diet drugs spent more than...
medpagetoday.com
Slippery Slope: Binge Eating Dx -- Gateway to Off-Label?
(MedPage Today) -- If an amphetamine is approved for binge-eating,...
medpagetoday.com
Slippery Slope: The Constant Quest for Quick-Fix Weight Loss
(MedPage Today) -- A brief history of diet drug use...
medpagetoday.com
Slippery Slope: Fen-Phen Users Recall a 'Miracle' Turned Nightmare
(MedPage Today) -- Two women who used fen-phen talk about...
medpagetoday.com
Slippery Slope: How the Diet Drug Series Was Produced
(MedPage Today) -- The methods reporters used to look at...
medpagetoday.com
Tofactinib's Effects on GFR and Creatinine Reassuring (CME/CE)
(MedPage Today) -- Changes not likely to be clinically meaningful...
medpagetoday.com
EGFR Mutation Testing in Advanced Lung Cancer Underused
(MedPage Today) -- Patients may not receive the best treatment...
medpagetoday.com
Novel Lymphoma Assay ID's Subtypes (CME/CE)
(MedPage Today) -- Method found to be more reliable than...
medpagetoday.com
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This weeks topics include PCSK9 inhibition, best...
medpagetoday.com
PPIs Linked to Kidney Failure in Seniors
(MedPage Today) -- Older patients taking proton pump inhibitors had...
medpagetoday.com
'Mysterious' disease kills 17 in Nigeria: official
A "mysterious" disease that kills patients within 24 hours has...
medicalxpress.com
Study reveals a cause of poorer outcomes for African-American patients with breast cancer
Poorer outcomes for African-American women with estrogen-receptor positive (ER+) breast...
medicalxpress.com
D.C. Week: Senate Passes SGR Repeal Bill, FDA Okays Heart Failure Drug
(MedPage Today) -- At last, senators pass bill to repeal...
medpagetoday.com
Cancer Society's Retiring Chief Shares Parting Thoughts
(MedPage Today) -- John Seffrin lifts the veil at the...
medpagetoday.com
A 65-Million-Year Rectal Foreign Body? That's Improbable!
(MedPage Today) -- The revealing of the self through ......
medpagetoday.com
CMS Proposes 1.1% Hospital Pay Raise for 2016
(MedPage Today) -- Hospitals that don't participate in quality reporting...
medpagetoday.com
House Panel Considers Medicare Reform for Post-Acute Care
(MedPage Today) -- Spending on post-acute care has outpaced most...
medpagetoday.com
 


Privacy Statement - Copyright Information. - Contact Us

comments powered by Disqus

Integrated Publishing, Inc.
9438 US Hwy 19N #311 Port Richey, FL 34668

Phone For Parts Inquiries: (727) 755-3260
Google +